Table
1. Comparison of scientific innovation and biotechnology development between Brazil, Argentina, Chile, United Kingdom and United States of America. |
BRAZIL |
ARGENTINA |
CHILE |
UK |
USA |
|
Population millions (2002) |
175.09 |
38.0 |
15.6 c |
58.8 e |
282.1 h |
No of biotechnology companies (2002) |
350 b |
250 a |
31 d |
550 f |
1,457 i |
Nº of companies / population (106) |
2 |
6.6 |
2 |
9.3 |
5.16 |
Total revenues of biotechnology industry |
7,000 b |
75 a |
10 |
4,700 f |
28,500 i |
Total revenue (106) / Nº of companies |
20 |
0.3 |
0.32 |
8.5 |
20 |
No of biological researchers (2000) |
20,233 |
9,587 |
1,860 |
47,000 g |
446,890 |
Nº of companies / Nº of biological researchers (103) |
17 |
26 |
17 |
12 |
3.2 |
% of GDP invested in Research and Development (2000) |
1.05 |
0.44 |
0.56 |
1.83 g |
2.68 |
No of scientific publications identified via Medline (2000) |
4,021 |
1,466 |
555 |
27,931 |
146,622 |
Total No of patent applications |
19,325 |
6,633 |
3,683 |
21,580 j |
295,000 |
Total No of granted patents |
9,269 |
1,587 |
620 |
2,962 j |
157,495 |
Nº of granted patents / Nº of patent applications |
0.48 |
0.24 |
0.17 |
0.14 |
0.53 |
|